bpc-157 ulcerative colitis phase ii trial JPP No 5/2013 article 09 1209_S7_article_20
Description
It works through a different mechanism (fat oxidation via beta-3 adrenergic receptors, not appetite suppression), and that mechanism produces gradual, subtle changes
TB-500 excels specifically at cell migration and soft tissue repair
injectable debate is irrelevant if the peptide itself is impure
Avoid screens for 30 minutes before bed
